JPRN-UMIN000014408已完成未知
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioning - JSCT-Haplo14 RIC
JSCT0 个研究点目标入组 62 人开始时间: 2014年7月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are positive for HBs antigen, HCV antibody, or HIV antibody. 2. Patients with active other malignancies. 3. Patients with active infectious disease. 4. Women who are pregnant, of childbearing potential, or lactating. 5. Patients who experienced serious hypersensitivity or anaphylaxis to cyclophosphamide, fludarabine, tacrolimus, mycophenolate mofetil. 6. Positive anti-donor HLA antibody. 7. Patients who need chemotherapy within 13 days before transplantation. 8. Patients who are not eligible for this study at the discretion of the investigator.
研究者
相似试验
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioninghematologic malignanciesJPRN-UMIN000020655JSCT42
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioningJPRN-UMIN000020656JSCT36
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioningJPRN-UMIN000014406JSCT38
已完成
不适用
A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions.AML,ALL,MDS,NHL,CML Neuroblastoma,Rhabdomyosarcoma,Ewing sarcomaJPRN-UMIN000030767Department of Pediatrics, Kanazawa University Hospital8
招募中
不适用
A study of haploidentical transplantation with post-transplant cyclophosphamideAML,ALL,MDS,NHL,MM,CMJPRN-UMIN000019089Department of Hematology, Kanazawa University Hospital40